Characteristics of antiretroviral resistance in participants from the SHIELD trial: a pharmacokinetic and safety study evaluating fostemsavir in children and adolescents living with multi-drug resistant HIV

18 Jul, 2025

Authors: Archary M, Frigati L, Violari A, Patel F, Strehlau R, Camacho-Gonzalez A, Maboa R , Rakhmanina N, Grasa C, Salvadori N, Nardone A, Than-In-At K, Parry C, Keegan M, López Varela E, Giaquinto C, Cressey TR, Rojo P

Presented at: IAS